Degarelix is a prescription medicine used in the treatment of advanced prostate cancer that works as a luteinizing hormone-releasing hormone (LHRH) antagonist, thus leading to lowered testosterone levels in the body. The gene discussed is GNRH1; the disease is prostate carcinoma.